BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Toshikuni N, Arisawa T, Tsutsumi M. Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality. World J Gastroenterol 2014; 20(11): 2876-2887 [PMID: 24659879 DOI: 10.3748/wjg.v20.i11.2876]
URL: https://www.wjgnet.com/1948-5182/full/v20/i11/2876.htm
Number Citing Articles
1
Fred F. Poordad. Presentation and complications associated with cirrhosis of the liverCurrent Medical Research and Opinion 2015; 31(5): 925 doi: 10.1185/03007995.2015.1021905
2
Partha K. Chandra, Feyza Gunduz, Sidhartha Hazari, Ramazan Kurt, Rajesh Panigrahi, Bret Poat, David Bruce, Ari J. Cohen, Humberto E. Behorquez, Ian Carmody, George Loss, Luis A. Balart, Tong Wu, Srikanta Dash, Ranjit Ray. Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver CirrhosisPLoS ONE 2014; 9(9): e108616 doi: 10.1371/journal.pone.0108616
3
Jana Enderes, Jessica Teschke, Steffen Manekeller, Tim O. Vilz, Jörg C. Kalff, Tim R. Glowka. Chronic Liver Disease Increases Mortality Following PancreatoduodenectomyJournal of Clinical Medicine 2021; 10(11): 2521 doi: 10.3390/jcm10112521
4
Allison Dormanesh, Judy Huei-yu Wang, Ranit Mishori, Paula Cupertino, Joshua Longcoy, Seble Kassaye, Linda Kaljee, Coleman Smith, Christopher A. Loffredo. Adherence to clinical follow-up recommendations for liver function tests: A cross-sectional study of patients with HCV and their associated risk behaviorsPreventive Medicine Reports 2021; 23: 101482 doi: 10.1016/j.pmedr.2021.101482
5
Tamami Abe, Hidekatsu Kuroda, Yudai Fujiwara, Yuichi Yoshida, Akio Miyasaka, Naohisa Kamiyama, Yasuhiro Takikawa. Accuracy of 2D shear wave elastography in the diagnosis of liver fibrosis in patients with chronic hepatitis CJournal of Clinical Ultrasound 2018; 46(5): 319 doi: 10.1002/jcu.22592
6
Orla Convery, Siobhan Gargan, Michelle Kickham, Martina Schroder, Cliona O'Farrelly, Nigel J. Stevenson. The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)‐ α via signal transducer and activator of transcription (STAT)3 and extracellular signal‐regulated kinase (ERK)–mediated induction of suppressor of cytokine signaling (SOCS)3 The FASEB Journal 2019; 33(8): 8732 doi: 10.1096/fj.201800629RR
7
José Velosa. Why is Viral Eradication so Important in Patients with HCV-Related Cirrhosis?Antiviral Therapy 2017; 22(1): 1 doi: 10.3851/IMP3077
8
Chen Zheng, Markus Schneider, Antoine Marion, Iris Antes. The Q41R mutation in the HCV-protease enhances the reactivity towards MAVS by suppressing non-reactive pathwaysPhysical Chemistry Chemical Physics 2022; 24(4): 2126 doi: 10.1039/D1CP05002H
9
Mai Abdel Moneim, Doaa H. Abdelaziz, Yosra Ibrahim Nagy, Amin Abdel Baki, Ahmed S. Attia, Nirmeen Sabry. Rifaximin microbial resistance and its efficacy and safety as a secondary prophylaxis of hepatic encephalopathy in patients with hepatitis C virus‐related cirrhosisInternational Journal of Clinical Practice 2021; 75(11) doi: 10.1111/ijcp.14807
10
Prabhav Kalaghatgi, Anna Maria Sikorski, Elena Knops, Daniel Rupp, Saleta Sierra, Eva Heger, Maria Neumann-Fraune, Bastian Beggel, Andreas Walker, Jörg Timm, Hauke Walter, Martin Obermeier, Rolf Kaiser, Ralf Bartenschlager, Thomas Lengauer, Luis Menéndez-Arias. Geno2pheno[HCV] – A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral AgentsPLOS ONE 2016; 11(5): e0155869 doi: 10.1371/journal.pone.0155869
11
Syed Manzoor Kadri, Marija Petkovic. Advances in Hepatology2021;  doi: 10.5772/intechopen.94879
12
María Llanos Valero, Rosario Sabariegos, Francisco J. Cimas, Celia Perales, Esteban Domingo, Ricardo Sánchez-Prieto, Antonio Mas. Hepatitis C Virus RNA-Dependent RNA Polymerase Interacts with the Akt/PKB Kinase and Induces Its Subcellular RelocalizationAntimicrobial Agents and Chemotherapy 2016; 60(6): 3540 doi: 10.1128/AAC.03019-15
13
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatmentWorld Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
14
Kosuke Takeda, Ryuichi Noguchi, Tadashi Namisaki, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Naotaka Shimozato, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Kenichiro Seki, Yukihisa Fujinaga, Yuki Tsuji, Takuya Kubo, Shinya Sato, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Daisuke Kaya, Akira Mitoro, Tsuyoshi Mashitani, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji. Efficacy and tolerability of interferon‑free regimen for patients with genotype‑1 HCV infectionExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6481
15
Junna Wang, Jiajun Li, Quan Zhou, Dandan Zhang, Qiu Bi, Yulin Wu, Wenxiang Huang. Liver stiffness measurement predicted liver‐related events and all‐cause mortality: A systematic review and nonlinear dose–response meta‐analysisHepatology Communications 2018; 2(4): 467 doi: 10.1002/hep4.1154
16
Seung Kak Shin, Jin-Woo Lee, Hannah Ra, Oh Sang Kwon, Jong-Beom Shin, Young-Joo Jin, Sangheun Lee, Ki Jun Han, Young Nam Kim, Tae Hun Kim, Yun Soo Kim, Ju Hyun Kim. Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter StudyJournal of Korean Medical Science 2019; 34(41) doi: 10.3346/jkms.2019.34.e264
17
Vijay Gayam, Arshpal Gill, Pavani Garlapati, Smruti Mohanty. Hepatitis B and C2020;  doi: 10.5772/intechopen.83609
18
Erin Kelty, Gary Hulse, David Joyce, David B. Preen. Impact of Pharmacological Treatments for Opioid Use Disorder on MortalityCNS Drugs 2020; 34(6): 629 doi: 10.1007/s40263-020-00719-3
19
José Carlos Rodrigues Nascimento, Lianna C Pereira, Juliana Magalhães C Rêgo, Ronaldo P Dias, Paulo Goberlânio B Silva, Silvio Alencar C Sobrinho, Gustavo R Coelho, Ivelise Regina C Brasil, Edmilson F Oliveira-Filho, James S Owen, Pierluigi Toniutto, Reinaldo B Oriá. Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosisWorld Journal of Gastroenterology 2021; 27(11): 1064-1075 doi: 10.3748/wjg.v27.i11.1064